MALATHION (malathion) by Pharmobedient is cholinesterase inhibitors [moa]. First approved in 2009.
Drug data last refreshed 13h ago
Cholinesterase Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Pharmobedient is hiring 1 role related to this product
Worked on MALATHION at Pharmobedient? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.